TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
36,320
|
41,393
|
31,678 |
Financial expenses |
412
|
18
|
178 |
Earnings before taxes |
388
|
1,040
|
522 |
EBITDA |
643
|
1,049
|
511 |
Total assets |
17,143
|
14,476
|
21,014 |
Current assets |
17,120
|
14,454
|
20,954 |
Current liabilities |
11,788
|
9,412
|
16,380 |
Equity capital |
4,093
|
3,806
|
3,265 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
21
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.9%
|
26.3%
|
15.5% |
Turnover per employee |
1,730
|
2,179
|
1,760 |
Profit as a percentage of turnover |
1.1%
|
2.5%
|
1.6% |
Return on assets (ROA) |
4.7%
|
7.3%
|
3.3% |
Current ratio |
145.2%
|
153.6%
|
127.9% |
Return on equity (ROE) |
9.5%
|
27.3%
|
16.0% |
Change turnover |
-5,194
|
12,281
|
458 |
Change turnover % |
-13%
|
42%
|
1% |
Chg. No. of employees |
2
|
1
|
2 |
Chg. No. of employees % |
11%
|
6%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.